# US 2017/0304319 A1 · Dexamethasone oral film

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0304319 A1
- Document ID: US20170304319A1
- Status: Published application
- Kind: A1
- Application number: 15/523,502
- Filed: 2015-11-04
- Published: 2017-10-26
- Earliest claimed: 2014-11-04
- Assignees: Acucort AB; LTS Lohmann Therapie-Systeme AG
- Applicants: Acucort AB; Lts Lohmann Therapie-Systeme AG
- Inventors: Bengt Arvid WESTRIN
- Web page: https://patentgrep.com/patent/US20170304319A1

## CPC

- A61K 31/573: substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 47/38: Cellulose; Derivatives thereof
- A61P 1/08: for nausea, cinetosis or vertigo; Antiemetics
- A61P 7/10: Antioedematous agents; Diuretics
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.

## Claims

### Claim at position 1

-18. (canceled)

### Claim 19

An oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w, all based on total dry matter.

### Claim 20 (depends on 19)

An oral film according to claim 19, wherein the sum of the concentrations of dexamethasone and hydroxypropyl methylcellulose is from 95% to 100% w/w.

### Claim 21 (depends on 19)

An oral film according to claim 19, wherein the hydroxypropyl methylcellulose is hypromellosum, Ph. Eur.

### Claim 22 (depends on 19)

An oral film according to claim 19, wherein the hydroxypropyl methylcellulose is hypromellose, USP.

### Claim 23 (depends on 19)

An oral film according to claim 19, wherein the hydroxypropyl methylcellulose is type 2910.

### Claim 24 (depends on 19)

An oral film according to claim 19, wherein the hydroxypropyl methylcellulose is a mixture of two or more hydroxypropyl methylcelluloses having different viscosity.

### Claim 25 (depends on 24)

An oral film according to claim 24, wherein the hydroxypropyl methylcellulose is a mixture of two hydroxypropyl methylcelluloses having different viscosity, wherein the concentrations of the two hydroxypropyl methylcelluloses in the film are the same.

### Claim 26 (depends on 19)

An oral film according to claim 19, wherein the hydroxypropyl methylcellulose is a mixture of hydroxypropyl methylcelluloses having a viscosity of 3 mPa s and 50 mPa s, respectively.

### Claim 27 (depends on 19)

An oral film according to claim 19, wherein the concentration of dexamethasone is from 35 to 45% w/w.

### Claim 28 (depends on 27)

An oral film according to claim 27, wherein the concentration of dexamethasone is 40% w/w.

### Claim 29 (depends on 19)

An oral film according to claim 19, wherein the total concentration of hydroxypropyl methylcellulose is from 55 to 65% w/w.

### Claim 30 (depends on 19)

An oral film according to claim 19, containing a mixture of two hydroxypropyl methylcelluloses having a viscosity of 3 mPa s and 50 mPa s, respectively, wherein the total concentration of the mixture is 60% w/w.

### Claim 31 (depends on 19)

An oral film according to claim 19, wherein dexamethasone is present in micronized form.

### Claim 32 (depends on 19)

An oral film according claim 19, wherein the film has a thickness of from 15 to 50 μm.

### Claim 33 (depends on 19)

An oral film according to claim 19 in unit dosage form.

### Claim 34 (depends on 33)

An oral film according to claim 33, wherein the unit dosage form contains from 4 to 10 mg of dexamethasone.

### Claim 35 (depends on 19)

A method of treating a condition selected from chemotherapy induced nausea, chemotherapy induced vomiting, croup, acute allergic conditions, anaphylactic conditions, brain oedema, and high-altitude disease, comprising orally administering an oral film according to claim 19 to a subject in need thereof.

### Claim 36 (depends on 19)

A method for preparing an oral film according to claim 19, comprising:
i) dispersing dexamethasone in water to obtain a dispersion,
ii) dissolving hydroxypropyl methylcellulose in said dispersion,
iii) coating the dispersion resulting from step ii) on an intermediate layer to obtain a wet film,
iv) drying the wet film, and
v) removing the intermediate layer.

### Claim 37 (depends on 19)

A method for preparing an oral film according to claim 19, comprising:
i) dissolving hydroxypropyl methylcellulose in water to obtain a homogeneous viscous solution,
ii) dispersing dexamethasone in said solution, and obtaining a homogeneous viscous dispersion containing all ingredients,
iii) coating the dispersion resulting from step ii) on an intermediate layer to obtain a wet film,
iv) drying the wet film, and
v) removing the intermediate layer.
